학술논문
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
Document Type
Artikel
Author
Source
Translational lung cancer research. 11(6):953-963
Subject
Language
English
English
English
ISSN
2218-6751